Yamada S M, Yamaguchi F, Morrison R S, Takahashi H, Teramoto A
Department of Neurosurgery, Nippon Medical School, Tokyo, Japan.
No To Shinkei. 1998 Dec;50(12):1101-5.
Although normal human astrocytes rarely express fibroblast growth factor receptor 1 (FGFR 1) mRNA, expression of FGFR 1 mRNA in astrocytomas increases as malignancy progresses. This result suggests that FGFR 1 can be one of important factors for glioblastoma cell growth. In our study, specific antisense oligonucleotides for FGFR 1 mRNA inhibited cell growth of SNB 19, human glioblastoma cell line, while sense oligonucleotides showed no cell reduction. And Southern blot analysis demonstrated decreased expression of FGFR 1 mRNA in only antisense group. Furthermore, cross-linking analysis revealed decreased number of FGFR 1 in antisense-treated SNB 19 in protein level. These results conclude that cell growth inhibition was caused by suppression of both transcription and translation of FGFR 1 mRNA. Interestingly, alpha-specific antisense also inhibited expression of beta-, and gamma-type of FGFR 1 mRNA which had no binding sites for the oligonucleotides. This fact indicates that antisense oligonucleotides binds to premature mRNA, which is previous form of mature mRNA before splicing, in nucleus. It is previously reported that basic fibroblast growth factor (bFGF), major ligand to FGFR 1, was overly expressed in human malignant astrocytomas. Thus, increased number of FGFR 1 may contribute to the acceleration of bFGF autocrine or paracrine mechanism in glioblastoma.
虽然正常人类星形胶质细胞很少表达成纤维细胞生长因子受体1(FGFR 1)mRNA,但在星形细胞瘤中,FGFR 1 mRNA的表达随着恶性程度的进展而增加。这一结果表明,FGFR 1可能是胶质母细胞瘤细胞生长的重要因素之一。在我们的研究中,针对FGFR 1 mRNA的特异性反义寡核苷酸抑制了人胶质母细胞瘤细胞系SNB 19的细胞生长,而正义寡核苷酸则没有使细胞数量减少。Southern印迹分析表明,仅在反义组中FGFR 1 mRNA的表达降低。此外,交联分析显示,在蛋白质水平上,反义处理的SNB 19中FGFR 1的数量减少。这些结果得出结论,细胞生长抑制是由FGFR 1 mRNA转录和翻译的抑制引起的。有趣的是,α特异性反义寡核苷酸也抑制了β-和γ型FGFR 1 mRNA的表达,而这些FGFR 1 mRNA没有寡核苷酸的结合位点。这一事实表明,反义寡核苷酸在细胞核中与前体mRNA结合,前体mRNA是成熟mRNA剪接前的形式。先前有报道称,FGFR 1的主要配体碱性成纤维细胞生长因子(bFGF)在人类恶性星形细胞瘤中过度表达。因此,FGFR 1数量的增加可能有助于胶质母细胞瘤中bFGF自分泌或旁分泌机制的加速。